The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Frontiers | Non-canonical Estrogen Signaling in Endocrine Resistance | Endocrinology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Integration of genomic and nongenomic/rapid ER signaling and its... | Download Scientific Diagram
ICI 182,780 ≥99% (HPLC) | 1047 | Tocris Bioscience
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Fulvestrant | Aromatase inhibitor | Buy Faslodex from Supplier AdooQ®
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Four major mechanisms of estrogen and estrogen receptors (ER). (I)... | Download Scientific Diagram
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
